hydralazine has been researched along with 20-hydroxy-5,8,11,14-eicosatetraenoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Capdevila, JH; Falck, JR; Gangadhariah, MH; Garcia, V; Hayward, SW; Imig, JD; Love, HD; Luther, JM; Manthati, VL; Paueksakon, P; Pozzi, A; Schwartzman, ML; Zent, R; Zhang, MZ | 1 |
1 other study(ies) available for hydralazine and 20-hydroxy-5,8,11,14-eicosatetraenoic acid
Article | Year |
---|---|
Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.
Topics: Animals; Collagen; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Diabetic Nephropathies; Glomerular Basement Membrane; Hydralazine; Hydrochlorothiazide; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mice, Knockout; Orchiectomy; Renin-Angiotensin System; Reserpine; Sodium | 2015 |